Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Peanut Allergy

In brief

This clinical research study investigates the safety, tolerability and efficacy of a peanut SLIT-tablet in adults, adolescents, and children with peanut allergy.

Key facts

Study ID
NCT05440643
Run by
ALK-Abelló A/S
People needed
209
Starts
2022-09-07
Expected to finish
2026-04-05
Last updated by the study team
2026-05-11

Who can join

Age: 4 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.